Respiratory Medicine
Volume 104, Issue 2 , Pages 197-203 , February 2010

Pulmonary function correlates with arterial stiffness in asthmatic patients

  • Zeev Weiler

      Affiliations

    • Pulmonary Unit, Barzilai Medical Center, Ashkelon 78306, Israel Affiliated to the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheba
    • Corresponding Author InformationCorresponding author. Tel./fax: +972 86745473.
  • ,
  • Yuri zeldin

      Affiliations

    • Allergy and Immunology Unit, Barzilai Medical Center, Ashkelon, Israel
  • ,
  • Eli Magen

      Affiliations

    • Internal Medicine Ward B, Barzilai Medical Center, Ashkelon, Israel
  • ,
  • Doron Zamir

      Affiliations

    • Internal Medicine Ward B, Barzilai Medical Center, Ashkelon, Israel
  • ,
  • Mona I. Kidon

      Affiliations

    • Allergy and Immunology Unit, Chaim-Sheba Medical Center, Tel-Hashomer, Israel
    • Corresponding Author InformationCorresponding author. Tel./fax: +972 39412038.

Received 11 June 2009 ,Accepted 6 September 2009.

References 

  1. Expert Panel Report 3 (EPR-3) . Guidelines for the diagnosis and management of asthma–summary report 2007. J Allergy Clin Immunol. 2007;120(Suppl. 5):S94–138
  2. Arif AA, Delclos GL, Colmer-Hamood J. Association between asthma, asthma symptoms and C-reactive protein in US adults: data from the National Health and Nutrition Examination Survey, 1999–2002. Respirology. 2007;12(5):675–682
  3. Butland BK, Strachan DP, Rudnicka AR. C-reactive protein, obesity, atopy and asthma symptoms in middle-aged adults. Eur Respir J. 2008;32(1):77–84
  4. Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma. 2003;40(7):733–739
  5. Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006;27(5):908–912
  6. Qian FH, Zhang Q, Zhou LF, Liu H, Huang M, Zhang XL, et al. High-sensitivity C-reactive protein: a predicative marker in severe asthma. Respirology. 2008;13(5):664–669
  7. Silvestri M, Bontempelli M, Giacomelli M, Malerba M, Rossi GA, Di Stefano A, et al. High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation?. Clin Exp Allergy. 2006;36(11):1373–1381
  8. Wu TL, Chang PY, Tsao KC, Sun CF, Wu LL, Wu JT. A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal. 2007;21(6):367–371
  9. Dogra S, Ardern CI, Baker J. The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma. 2007;44(10):849–854
  10. Schanen JG, Iribarren C, Shahar E, Punjabi NM, Rich SS, Sorlie PD, et al. Asthma and incident cardiovascular disease: the atherosclerosis risk in communities study. Thorax. 2005;60(8):633–638
  11. Toren K, Lindholm NB. Do patients with severe asthma run an increased risk from ischaemic heart disease?. Int J Epidemiol. 1996;25(3):617–620
  12. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874
  13. Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103(5):398–406
  14. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46(5):1118–1122
  15. Anderson TJ. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol. 2006;22(Suppl. B):72B–80B
  16. Ramasamy R, Yan SF, Herold K, Clynes R, Schmidt AM. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci. 2008;1126:7–13
  17. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6(6):399–409
  18. Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens. 2001;14(8 Pt 2):258S–263S
  19. Cohn JN, Duprez DA, Grandits GA. Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. Hypertension. 2005;46(1):217–220
  20. Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H. Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens. 2002;15(5):453–458
  21. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605
  22. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15(5):426–444
  23. Duprez DA, De Buyzere ML, De Backer TL, Van DV, Clement DL, Cohn JN. Relationship between arterial elasticity indices and carotid artery intima-media thickness. Am J Hypertens. 2000;13(11):1226–1232
  24. Duprez DA, Cohn JN. Arterial stiffness as a risk factor for coronary atherosclerosis. Curr Atheroscler Rep. 2007;9(2):139–144
  25. Boussuges A, Rossi P, Gouitaa M, Nussbaum E. Alterations in the peripheral circulation in COPD patients. Clin Physiol Funct Imaging. 2007;27(5):284–290
  26. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(12):1259–1265
  27. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136
  28. Sherrill DL, Lebowitz MD, Knudson RJ, Burrows B. Methodology for generating continuous prediction equations for pulmonary function measures. Comput Biomed Res. 1991;24(3):249–260
  29. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999 Am J Respir Crit Care Med. 2000;161(1):309–329
  30. Tantisira KG, Fuhlbrigge AL, Tonascia J, Van Natta M, Zeiger RS, Strunk RC, et al. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol. 2006;117(6):1264–1271
  31. Onufrak S, Abramson J, Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2007;195(1):129–137
  32. Onufrak SJ, Abramson JL, Austin HD, Holguin F, McClellan WM, Vaccarino LV. Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol. 2008;101(9):1247–1252
  33. Sanderson MJ, Delmotte P, Bai Y, Perez-Zogbhi JF. Regulation of airway smooth muscle cell contractility by Ca2+ signaling and sensitivity. Proc Am Thorac Soc. 2008;5(1):23–31
  34. Bentley JK, Hershenson MB. Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. Proc Am Thorac Soc. 2008;5(1):89–96
  35. Appleton SL, Ruffin RE, Wilson DH, Taylor AW, Adams RJ. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol. 2009;123(1):124–130
  36. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004;125(6):2309–2321
  37. Allayee H, Hartiala J, Lee W, Mehrabian M, Irvin CG, Conti DV, et al. The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. Chest. 2007;132(3):868–874
  38. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–336
  39. Suissa S, Assimes T, Brassard P, Ernst P. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med. 2003;115(5):377–381

PII: S0954-6111(09)00302-3

doi: 10.1016/j.rmed.2009.09.004

Respiratory Medicine
Volume 104, Issue 2 , Pages 197-203 , February 2010